Promising chordoma-specific immunotherapy trial now open at two sites
Launched last spring, a Phase 1 clinical trial studying the safety and initial effectiveness of the immunotherapy drug nivolumab with and … Continue reading
Category Archives: Research
Top 10 Takeaways from 6th International Chordoma Research Workshop
In March of 2018, 140 doctors and scientists from more than ten countries and 70 institutions braved a nor’easter to … Continue reading
Chordoma Foundation presents poster at American Association for Cancer Research’s 2018 meeting
Last month, Director of Research Joan Levy and Manager of Research Patty Cogswell joined more than 20,000 scientists, clinicians, and … Continue reading
Announcing $1.5M Pediatric Chordoma Initiative
As part of the Chordoma Foundation’s commitment to ensuring that all chordoma patients benefit from advances in research, we are … Continue reading
Enrollment temporarily suspended for Epizyme’s tazemetostat trial
On Monday, April 23, the United States Food and Drug Administration (FDA) issued a temporary clinical hold, meaning a pause … Continue reading
New funding opportunity offered in partnership with the Canadian Cancer Society
Our collaboration with the Canadian Cancer Society (CCS), initiated in 2017, progressed last month with the announcement of a new … Continue reading
Chordoma Foundation Biobank Collaborates with Children’s Hospital of Philadelphia
Last fall, the Chordoma Foundation launched a groundbreaking collaboration with Children’s Hospital of Philadelphia (CHOP), one of the nation’s leading … Continue reading
New funding opportunity: Therapeutic Innovation Award
The Chordoma Foundation is pleased to announce an exciting new funding opportunity aimed at accelerating the development of drug therapies … Continue reading
Accelerating drug therapies from the bench to the clinic
Thanks to the robust scientific infrastructure built by the Chordoma Foundation over the last decade, chordoma research is thriving. With … Continue reading
New clinical trial opens testing targeted cancer therapy, palbociclib
A new clinical trial has opened for chordoma patients with locally advanced or metastatic tumors testing the effectiveness of a … Continue reading